XELACRT
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for XELACRT, covering 2012-07-31 to 2012-07-31. Get the full timeline:
Most recent: Clinical Trial Update: Preoperative Downstaging of Extraperitoneal T3 Rectal Cancer: XELOXRT Versus XELACRT. A Multicenter, Phase III Study [Phase 3]